Weekly research digest
| AI Quant portfolio | AI Quant | S&P 500 |
|---|---|---|
| Week to 16 Oct | -0.3% | -2.0% |
| Since inception | +12.0% | +14.4% |
| Since inception, at market β | +44.4% | +14.4% |
| Sharpe | 2.76 | 1.71 |
| Beta | 0.27 | 1.00 |
At market β restates the record at the market's beta — the same strategies held at 3.70× the exposure: the return is multiplied by that factor, the drawdown re-measured on the scaled line, and Sharpe is unchanged by it. Arithmetic on the record, not a second track record — no leverage was used and no financing cost is modelled.
Daily estimates a constrained Kelly allocation across SPY and GLD, then scales its active deviation from a 100% SPY benchmark to prescribed drawdown-risk targets. Infeasible rebalances are skipped rather than clipped or partially executed.
we backtested it — Sharpe -0.82 · quant relevance 1.00
The paper uses portfolio-performance attributions to adjust machine-learning statistical-arbitrage allocations without retraining. It reports improved out-of-sample net Sharpe ratios for US equity portfolios, but our shorter data history cannot reproduce its full 2006–2024 test.
we backtested it — Sharpe 0.83 · quant relevance 0.98
AlphaRLM trains a language model to generate symbolic stock-selection factors and reports improved backtested excess returns. Its US-equity factor evaluation is testable here, but the literature-conditioned reinforcement-learning method and Chinese-market results are not reproducible with the stated resources.
we backtested it — Sharpe -0.29 · quant relevance 0.98
The paper derives an alpha-aware execution horizon and a front-loaded schedule under concave impact and Hurst-scaled price risk. Its reported 10–17% cost saving comes from the execution-cost model, not measured trading performance.
we backtested it — Sharpe -0.73 · quant relevance 0.98
The paper tests news-topic attention and stock exposures as cross-sectional return signals for US equities. Its reported ensemble performance does not significantly beat a price-only benchmark. A forward-shifted version is backtestable, but the platform cannot reproduce the early training sample or the NoLBERT comparison.
we backtested it — Sharpe 2.62 · quant relevance 0.98
The paper tests a daily, news-informed actor-critic policy for allocating among U.S. equities, with downside-risk and turnover penalties. Its reported performance applies to its own small equity portfolios; our shorter news history cannot reproduce its 11-year test.
69 new papers written up in this period. Open the Quant Paper Radar →
Backtests are hypothetical research results; forward-portfolio figures are a live record. Neither is a guarantee of future performance. Research and education only: not individualised investment advice, not an offer to sell or a solicitation of an offer to buy any security.